Lipoprotein Apheresis Alleviates Treatment-Resistant Peripheral Artery Disease Despite the Normal Range of Atherogenic Lipoproteins: The LETS-PAD Study.
Ueda E, Toya Y, Wakui H, Ishiga K, Kawai Y, Kobayashi R, Kinguchi S, Kanaoka T, Saigusa Y, Mikami T, Yabuki Y, Goda M, Machida D, Fujita T, Haruhara K, Sugano T, Azushima K, Tamura K.
Ueda E, et al. Among authors: yabuki y.
J Atheroscler Thromb. 2024 Apr 3. doi: 10.5551/jat.64639. Online ahead of print.
J Atheroscler Thromb. 2024.
PMID: 38569869
Free article.